Home > Insider Trading > Filing (0001179110-21-010165)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
744218	Celldex Therapeutics Inc.	CLDX	In Vitro & In Vivo Diagnostic Substances (2835)	133191702

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1648010	C. Diane Young	C/O Celldex Therapeutics, Inc. 53 Frontage Road, Suite 220 Hampton NJ 08827	Svp, Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-11-12	4,600	$10.38	6,715	No	4	M	Direct
Common Stock	Disposition	2021-11-12	4,600	$42.94	2,115	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Option (Right to Buy)	Disposition	2021-11-12	4,600	$0.00	4,600	$10.38

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
67,400		2030-06-18	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.6400 to $43.2000 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.